Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Berg

Showing results (681-690 of 936) with videos related to

Pageof 94
Sort By:
Plos Medicine|May 26, 2017
Data sharing in clinical trials: An experience with two large cancer screening trialsClaire S Zhu, Paul F Pinsky, James E Moler, et al.
Lancet (London, England)|June 17, 1989
Ovulation induction and neural tube defectsM C Cornel, L P ten Kate, M N Dukes, et al.
JACC. Advances|December 25, 2024
Mixed Cardiogenic-Vasodilatory Shock: Current Insights and Future DirectionsJacob C Jentzer, David D Berg, Meshe D Chonde, et al.
Cancer|August 14, 2002
Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinomaStephen B Edge, Karen Gold, Christine D Berg, et al.
The Lancet. Respiratory Medicine|May 12, 2019
Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocolHilary A Robbins, Matthew Callister, Peter Sasieni, et al.
The Journal of Molecular Diagnostics : JMD|January 23, 2004
Molecular diagnosis of metastasizing oligodendroglioma: a case reportMin Wang, Kathleen M Murphy, Piotr Kulesza, et al.
The British Journal of Dermatology|February 1, 2006
Reduction of immunosuppression for transplant-associated skin cancer: expert consensus surveyC C Otley, D Berg, C Ulrich, et al.
The New England Journal of Medicine|July 19, 2013
Targeting of low-dose CT screening according to the risk of lung-cancer deathStephanie A Kovalchik, Martin Tammemagi, Christine D Berg, et al.
Disease Management : DM|December 15, 2005
What can a pilot congestive heart failure disease management program tell us about likely return on investment?: A case study from a program offered to federal employeesCatherine J vanVonno, Ronald J Ozminkowski, Mark W Smith, et al.
Journal of the American College of Cardiology|August 6, 2021
A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48David D Berg, Robert P Giugliano, Christian T Ruff, et al.
Pageof 94

Showing results (681-690 of 936) with videos related to

Sort By:
Pageof 94
Plos Medicine|May 26, 2017
Data sharing in clinical trials: An experience with two large cancer screening trialsClaire S Zhu, Paul F Pinsky, James E Moler, et al.
Lancet (London, England)|June 17, 1989
Ovulation induction and neural tube defectsM C Cornel, L P ten Kate, M N Dukes, et al.
JACC. Advances|December 25, 2024
Mixed Cardiogenic-Vasodilatory Shock: Current Insights and Future DirectionsJacob C Jentzer, David D Berg, Meshe D Chonde, et al.
Cancer|August 14, 2002
Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinomaStephen B Edge, Karen Gold, Christine D Berg, et al.
The Lancet. Respiratory Medicine|May 12, 2019
Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocolHilary A Robbins, Matthew Callister, Peter Sasieni, et al.
The Journal of Molecular Diagnostics : JMD|January 23, 2004
Molecular diagnosis of metastasizing oligodendroglioma: a case reportMin Wang, Kathleen M Murphy, Piotr Kulesza, et al.
The British Journal of Dermatology|February 1, 2006
Reduction of immunosuppression for transplant-associated skin cancer: expert consensus surveyC C Otley, D Berg, C Ulrich, et al.
The New England Journal of Medicine|July 19, 2013
Targeting of low-dose CT screening according to the risk of lung-cancer deathStephanie A Kovalchik, Martin Tammemagi, Christine D Berg, et al.
Disease Management : DM|December 15, 2005
What can a pilot congestive heart failure disease management program tell us about likely return on investment?: A case study from a program offered to federal employeesCatherine J vanVonno, Ronald J Ozminkowski, Mark W Smith, et al.
Journal of the American College of Cardiology|August 6, 2021
A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48David D Berg, Robert P Giugliano, Christian T Ruff, et al.
Pageof 94